Patience Pays... Catalysts are coming. Better they waited so that we get the catalysts in the run up to the 3rd Quarter finacials with the expected conference call.
Patent appears to have been approved, but won't be official until October 15th and that was a must get that was a make, or break.
Now with a patent for MST-188 for specific type manufacturing processes and indications including combo therapy there is value in its success.
That could catalyst the share price to fill the gap back up to .70 cents.
The conference in May pulled about a dozen long term investment agencies. Another large buy and there will be no float. Buying 10 to 50 thousand shares has little effect but another quarter million buy can push this 20% in a day.
I am the first to tell you I have been disappointed in the past with the lack of prs and press releases.
They have had 3 conferences in 4 months to seek new investors. I am sure they could care less about my complaining I have sent in emails and calls in the past. On the positive at least they are trying to market this. That's what I feel they should have been doing all along.
News 
Market Data 
Discover 
AI
